Metraipolis › archive › dc_5992bcc407ef

Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients — Europe PMC PMID:40547037

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40547037
DOI
10.3389/fimmu.2025.1573365
License (as archived)
solo-consultazione
Archived
2026-10-10T00:10:04.210Z
SHA-256 of the archived text
37158e482fd4e0ad07a4a493c42edc672dac627e5cd39da7418b992e2f6e9015
Stable URL of this page
https://metraipolis.com/documento/dc_5992bcc407ef

How to cite

Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients — Europe PMC PMID:40547037 — Europe PMC (en), https://europepmc.org/article/MED/40547037 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5992bcc407ef (Metraipolis archive dc_5992bcc407ef, sha256 37158e482fd4e0ad07a4a493c42edc672dac627e5cd39da7418b992e2f6e9015)
BibTeX
@misc{dc5992bcc407ef,
  title = {Elevated Siglec-7 expression correlates with adverse clinicopathological, immunological, and therapeutic response signatures in breast cancer patients — Europe PMC PMID:40547037},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40547037},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5992bcc407ef; sha256 37158e482fd4e0ad07a4a493c42edc672dac627e5cd39da7418b992e2f6e9015},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40547037. Agents can read the archived copy with the MCP tool read_document.